Blinded in silico drug trial reveals the minimum set of ion channels for torsades de pointes risk assessment. Zhou X, Qu Y, Passini E, Bueno-Orovio A, Liu Y, Vargas H, Rodriguez B. Frontiers in Pharmacology. 2020. 10:1643. Partner involved: UOXF
Blinded in silico drug trial reveals the minimum set of ion channels for torsades de pointes risk assessment. Zhou X, Qu Y, Passini E, Bueno-Orovio A, Liu Y, Vargas H, Rodriguez B. Frontiers in Pharmacology. 2020. 10:1643. Partner involved: UOXF